טוען...
Glutaminase-1 (GLS1) inhibition limits metastatic progression in osteosarcoma
BACKGROUND: Osteosarcoma (OS) is a malignant bone tumor that often develops during the period of rapid growth associated with adolescence. Despite successful primary tumor control accompanied by adjuvant chemotherapy, death from pulmonary metastases occurs in approximately 30% of patients within 5 y...
שמור ב:
| הוצא לאור ב: | Cancer Metab |
|---|---|
| Main Authors: | , , , , , , , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
BioMed Central
2020
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7057558/ https://ncbi.nlm.nih.gov/pubmed/32158544 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40170-020-0209-8 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|